United States Antifungal Prescription Pharmaceutical Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Antifungal Prescription Pharmaceutical Markets, Executive SummaryIntroduction to the U.S. Prescription Antifungal MarketIntroduction to the U.S. Prescription Antifungal MarketObjectives and PurposeReport Scope and SegmentationDisease Overview: Fungi as Human PathogensFungal Infection OverviewPatient Population OverviewReport Structure Summary of Major FindingsMarket Drivers and RestraintsTotal Revenue and Revenue Growth RatesPercent of Total Revenues by Product Type Analysis by Major SegmentCompetitive AnalysisConclusionUnited States Antifungal Prescription Pharmaceutical Markets, Market Engineering Research MethodologyFrost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare IndustryFrost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare IndustryResearch SourcesSecondary SourcesPrimary ResearchPharmaceutical Forecast ModelPharmaceutical Forecast ModelPopulation-Based ForecastProduct-Based ForecastMarket Model Assumptions Research Limitations Presentation of Market Engineering Measurements, Definition and their Strategic SignificancePresentation of Market Engineering Measurements, Definition and their Strategic SignificanceGlossary of TermsList of DefinitionsList of AcronymsUnited States Antifungal Prescription Pharmaceutical Markets, Challenges in the U.S. Prescription Antifungal MarketIdentification of Challenges Facing the U.S. Prescription Antifungal MarketIdentification of Challenges Facing the U.S. Prescription Antifungal MarketIndustry ChallengesDiscovering Novel Drugs with Less Toxic Profiles Determines Future Market LeadersUnder-Reporting of Mycotic Infections Undermines Market Growth and Direction of AntifungalsLack of Sensitive Diagnostic Methods Negatively Impacts Number of Diagnosed PatientsReduced Drug Interaction Profiles Positively Impacts Product PenetrationIncreased Understanding of Fungal Cell Function and Proliferation Will Create Novel Mechanisms of AttackGrowing Resistance of Candida Isolates May Incapacitate Effectiveness of Antifungals Increased Long-Term Patient Data Propels Greater Prescribing for Newly Marketed DrugsPersistent Collaboration Between Industry and Public Health Organizations Boosts Awareness of Mycoses IssuesEmergence of New Pathogens Will Present New Drug Resistance Challenges with Currently Used Antifungal DrugsMarket Engineering Research for the U.S. Polyene Antifungal MarketMarket Overview and DefinitionsOverviewDefinitionScope/SegmentationHistoryIndication OverviewMarket Engineering Measurement SystemMarket Engineering Measurement SystemMarket DriversMarket DriversIncreasing Number of Immunocompromised Patients Drives Growth of Antifungal TherapySafer Profile of Novel Polyene Drugs Expedites Product Uptake Prophylaxis Indication Offers Future Growth ProspectsClinical Trials Supports Use of Novel ProductsAggressive Promotional Campaigns Drive Market GrowthEarly Discharge from Hospitals Increases Volume of Treatable Patients with Fungal Infections Triazole Resistance Drives Physicians to Seek AlternativesMarket RestraintsMarket RestraintsHigh Treatment Costs Restrict Market PotentialPhysicians’ Hesitancy to Prescribe Slows Uptake of Novel Products Increasing Competition from Emerging Therapies Slows Market Growth of Novel ProductsMarket Engineering Revenue Forecasts (1995-2005)Patient Population (Demand Analysis)Pricing AnalysisRevenuesRevenue Trends Technology TrendsCompetitive AnalysisCompetitive StructureCompetitive FactorsMergers, Alliances, and AcquisitionsMarket Share AnalysisMarket Share Winners and WhyMarket Share Losers and WhyProduct AnalysisProducts on the MarketProducts in Clinical TrialsProducts in DevelopmentMarket Engineering Research for the U.S. Prescription Triazole Market Market Overview and DefinitionsOverviewDefinitions and Product OverviewScope/SegmentationHistoryIndication OverviewMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversExpanding Immunocompromised Market Base Increases Demand for AntifungalsFavorable Studies in Children Boosts Prescriptions Absence of Standard Prophylaxis Antifungal Therapy Creates Need in a Largely Unclaimed MarketDirect-to-Consumer Advertising Supplementation Increases Public Awareness and PrescriptionsNovel Triazole Agents Benefit from Fluconazole Resistance ConcernsMarket RestraintsMarket RestraintsPatent Expiration of Blockbuster Triazoles Prompts Significant Shrinkage in Market GrowthNegative Perceptions of Drug Resistance Hampers Market Uptake Declining Incidence of HIV-Related Fungal Infections Reduces Market Potential of AntifungalsMarket Engineering Revenue Forecasts (1995-2005)Patient Population (Demand Analysis)Pricing AnalysisRevenuesTechnology TrendsCompetitive AnalysisCompetitive StructureCompetitive FactorsMergers, Alliances, and AcquisitionsMarket Share AnalysisMarket Share Winners and WhyMarket Share Losers and WhyProduct AnalysisProducts on the MarketProducts in Clinical DevelopmentProducts in DevelopmentMarket Engineering Research for the U.S. Prescription Imidazole MarketMarket Overview and DefinitionsOverviewDefinitionScope/SegmentationHistoryIndication OverviewMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversGrowth in Infection-Prone Age Cohorts Increase Potential Patient Population OTC Drugs Have Brought Infection Awareness to PublicExpanding Immunocompromised Patient Base Drives Demand for AntifungalsLower Costs Keep Imidazole Drugs a Viable OptionMarket RestraintsMarket RestraintsShorter Treatment Regimens of OTC Products Decreases the Need for Prescription Therapies Preference to Self-Diagnose by End-Users Decreases Demand for Prescription Products Generic Imidazoles Decrease Branded Product Market Shares Imidazole-Triazole Inverse Relationship Decreases Imidazole Prescriptions in HospitalsAdverse Drug Interaction Profile Detracts Usage from Specific Patient PopulationsFungal Resistance to Imidazoles Reduces Market PotentialMarket Engineering Revenue Forecasts (1995-2005)Patient Population (Demand Analysis)Pricing AnalysisRevenuesCompetitive AnalysisCompetitive StructureCompetitive FactorsMergers, Alliances, and AcquisitionsMarket Share AnalysisMarket Share Winners and WhyMarket Share Losers and WhyProduct AnalysisProducts on the MarketProducts in Clinical TrialsProducts in DevelopmentMarket Engineering Research for the U.S. Other Prescription Antifungals Market Market Overview and DefinitionsOverviewDefinitionDrug OverviewScope/SegmentationHistoryIndication OverviewMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversPatient Population Customer Base Expanding Novel Product Classes Gather Focus on Different Mechanisms of Attack; Displaying a Superior Profile over ImidazolesEmerging Product Classes to Increase Total Market Effective Therapies from Novel Product Classes Have Potential Prophylactic ApplicationsDTC Programs Educating Public of Nail Infections Increases Total Market Market RestraintsMarket RestraintsSelf-Diagnosis by End-Users Increases Demand for OTC Fungal Medications Promoting Prescription-to-OTC SwitchesBrand Loyalty May Hinder Success for Emerging Products Market Engineering Unit and Revenue Forecasts (1995-2005)Patient Population (Demand Analysis)Pricing AnalysisRevenuesCompetitive AnalysisCompetitive StructureCompetitive FactorsMergers, Alliances, and AcquisitionsMarket Share AnalysisMarket Share Winners and WhyMarket Share Losers and WhyProduct AnalysisProducts on the MarketProducts in Clinical TrialsProducts in Development




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.